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 Chrysanthemum cinerariifolium (Trev.) is a plant that has potential as an anticancer. 
This study aimed to predict the inhibitor of estrogen alpha and toxicity of compounds in 
96% ethanol extract of C. cinerariifolium leaves in silico. Prediction of the activity of 
metabolic profiling compounds produced by UPLC QToF MS/MS ethanol extract 96% of C. 
cinerariifolium leaves towards alpha estrogen receptors (ER-α) (5W9C) was carried out 
using Molegro Virtual Docker. The docking results showed that the compound (2-Methyl-
1,4-piperazinediyl) bis-[(3,4,5-trimethoxyphenyl)-methanone and Azoxystrobin have good 
activity compared to Tamoxifen, because these compounds have a lower Rerank Score. 
The activity of the test compound is also shown by the bonding of active amino acids (Arg 
394, Asp351, Glu 353, and Val 533). As for the toxicity class based on Globally Harmonized 
System (GHS) and Lethal Dose 50 (LD50) values, the ten docking compounds had a relatively 
low toxicity.
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INTRODUCTION
 Breast cancer is a cancer that develops from 
breast tissue. It is the most common invasive cancer 
in women. Signs of breast cancer include a lump in 
the breast, a change in breast shape, dimpling of the 
skin, nipple discharge, or a red scaly patch of skin 
(Kabel and Baali, 2015). During 2014 in Indonesia, 
breast cancer ranked first among women with 
48,998, above cervical cancer (20,928 events), and 
colorectal cancer (11,787 events) (WHO, 2014). 
The development of breast cancer cells occurs by 
several factors: estrogen and estrogen receptors. 
High estrogen levels and excessive expression of 
alpha estrogen receptors (ER-α) can trigger the 
development of breast cancer cells (Hayashi, 2003). 
Alpha estrogen receptors are called molecular 
targets that suppress proliferation of breast cancer 
cells. ER-α are used as the main marker to identify 
the presence of tumors in breast tissue (Setiawati, et 
al., 2014). Beta estrogen receptors (ER-β) has the 
same structural domains as ER-α, but its function is 
not exactly the same as ER-α. The role of ER-β in 
breast cancer remains elusive, and ER-β is currently 
not used in the diagnosis or treatment of breast 
cancer patients (Leygue and Murphy, 2013).
 The hormonal drug used in people with 
breast cancer is Tamoxifen. This drug works as 
an estrogen receptor antagonist in the breast. 
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However, Tamoxifen also has side effects, including 
thromboembolism, non-alcoholic fatty liver 
disease, and increased proliferation of endometrial 
carcinoma (Dermawan, et al., 2019). It is necessary 
to find new treatments to reduce these side effects, 
such as using medicinal plants (Katno and Pramono, 
2017).
 One of  the  plants that can be used empirically 
as an anticancer is C. cinerariifolium (Alviana, et 
al., 2016; Listiyana, et al., 2019). Previous studies 
have reported that terpenoids and flavonoids include 
dominant compounds in the Chrysanthemum plant 
(Ukiya, et al., 2002). Flavonoid compounds can 
be called SERMs, which can enter cells and bind 
with ER-α and form complex bonds, then bind to 
estrogen response element (ERE) and activate an 
NCoR co-repressor protein and suppress cancer cell 
replication so that its proliferation can be controlled 
(Bryant, 2002; Girault, et al., 2006). Listiyana, et 
al. (2019) identified the metabolite profile of 96% 
ethanol extract of C. cinerariifolium leaves using 
UPLC-QToF-MS/MS, so in this research prediction 
of the compound content of C. cinerariifolium 
leaves which has potential as breast anticancer with 
in silico method.
 The in silico approach with molecular 
modeling on the development of computational 
chemistry is currently utilized to develop new 
drugs. This computational chemical technique can 
accelerate the selection of isolated and synthesized 
compounds by identifying and optimizing guiding 
compounds in the drug discovery process. In this 
study, we performed the prediction inhibitor of 
ER-α and toxicity of the compounds in 96% ethanol 
extract of C. cinerariifolium leaves towards ER-α.
MATERIALS AND METHODS
Materials
 The device used was a laptop with 
specifications: Intel® InsideTM CORETM i3 
processor, 4GB RAM, and 600GB hard disk and 
Windows TM Seven Ultimate operating system 
software. Programs used include Chem-Bio Ultra 
12.0, pkCSM online tool, Protox II online tool, and 
Molegro Virtual Docker 6.0. While the material was 
a three-dimensional estrogen alpha structure (PDB: 




 Two-dimensional molecular structure of 
the compound produced by metabolite profiling on 
ethanol leaves extracted 96% of C. cinerariifolium 
with Chem-Bio Ultra 12.0 and copied by the 
SMILES code in SwissADME application, then 
selected the compounds according to parameters 
(not penetrate the brain barrier, P-GP non-substrate, 
and based on the criteria of the Lipinski Rules of 
Five (MW≤500 g/mol, log P value≤5, HBD≤5, 
HBA≤10, TPSA≤140 Å and Torsion≤10)).
Ligand-Protein Docking
Sample Preparation
 ER-α (PDB:5W9C) was download at PDB 
(https://www.rcsb.org/). The test compound the 
energy minimization of the compound that passed 
was tested by pressing MMFF94 in the Avogadro 
application, then stored in the form of mol2 
{SYBYL2 (*. Mol2)}.
Docking Molecular
 The detection of cavities by a selected 
cavity had an RMSD value≤2. Then, put the 3D 
structure of compounds that passed screening into 
the selected cavity, then docking of the compound 
to the receptor by using the Molegro Virtual Docker 
version 6.0. To measure the strength of drug binding 
to the receptor, the Rerank Score can be seen.
Toxicity Prediction
 The prediction of toxicity parameters of 
each compound uses the SMILES code. The code 
entered in the pkCSM application (http://biosig.
unimelb.edu.au/pkcsm/prediction) to predict 
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Lethal Dose 50 (LD50) values, Ames toxicity, 
and Hepatotoxicity. Meanwhile, to predict the 
toxicity of compounds LD50 based on the Globally 




 The initial step in this research is screening 
compounds using the SwissADME program. In 
this research, the samples used were 35 compounds 
resulting from metabolite profiling UPLC-QToF-
MS/MS ethanol extract 96% of C. cinerariifolium 
leaves (Table 1) (Listiyana, et al., 2019). The results 
of screening compounds through Boiled-Eggs can 
be observed in Figure 1.
 Based on these images of 35 compounds 
screened using the SwissADME application (A), 
only 10 compounds that passed with parameters 
not penetrate the blood brain barrier, P-gp non-
substrate, and based on the criteria of the Five 
Lipinski Rules (B). Furthermore, ten compounds 
which pass screening will be molecular docking to 
ER-α (PDB: 5W9C).
Ligand-Protein Docking
 The next step is the docking molecular. This 
step aimed to discover the interaction of compounds 
that pass screening with the target receptor (Ekins, 
et al., 2007). The receptor used in this study is the 
alpha estrogen receptor (PDB: 5W9C). The RMSD 
value of this receptor is 1.0354 of cavity 7 with 
ligand A, 0.9348 of cavity 8 with ligand B, 0.8501 
of cavity 6 with ligand C, and 1.0224 of cavity 5 
with ligand D. 
 The smaller RMSD value obtained 
indicates that the predicted pose ligand is getting 
better because it is getting closer to native ligand 
conformation (Susanti, et al., 2018). So that the 
hole (cavity) used is cavity 6 with ligand native 
C. The next step is docking simulation with a 
scoring parameter where the parameter is a score 
that can measure the strength of the drug bond with 
the receptor. The docking results obtained in this 
research shown in Figure 2, Figure 3, and Table 2.
 Based on visualization results on hydrogen 
interactions, native ligands bind two key residues, 
namely Glu 353 (C) and Arg 394 (C). Compounds 
that bind to amino acids are the same as native ligands 
in hydrogen interactions, including (2R) -2-Amino-
3-Trisulfanyl-propanal, Azoxystrobin, Genistein, 
Isorhamnetin, Kaempferol, and Isoleucine-Alanine 
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Table 1. Compounds resulting from metabolite profilling UPLC-QTOF-MS/MS ethanol extract 96% leaves of 
C. culinerifolium (Listiyana, et al., 2019):
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dipeptide. As for the comparative drug (Tamoxifen) 
only binds to Asp 351 (C) and does not bind the 
amino acids Glu 353 (C) and Arg 394 (C). In the 
study of Dermawan, et al. (2019), Tamoxifen forms 
hydrogen bonds with amino acid residues Glu 353 
and Arg 394. The hydroxyl group of the phenol 
in 4-hydroxytamoxifen establishes a tridentate 
hydrogen bond interaction with the carboxylate of 
Glu 353, a molecule of water and the guanidinium 
of Arg 394. The phenolic group is referred to the 
motor of binding for estrogens and antiestrogen to 
the ER (Médina, et al. 2004).
 Active amino acids in steric bonds found 
in native ligands are Asp 351 (C), Val 533 (C), 
Glu 353 (C), and Arg 394 (C). The compounds 
that bind amino acids together with native ligands 
in steric interactions include: (2R) -2-Amino-3-
Trisulfanylpropanal, Azoxystrobin, Genistein, 
Isorhamnetin, (2-Methyl-1,4-piperazinediyl) bis 
[(3, 4, 5-tri-methoxyphenyl) methanone], 1-Acetyl 
-3-piperidine carbohydrazide, Kaempferol, and 
Isoleucine Alanine dipeptide. For electrostatic 
interactions in native ligands and comparative 
drugs, only Asp 351 (C) while in the ligands tested 
none bonded the amino acid Asp 351 (C).
Prediction of Toxicity
 The next step is to predict the toxicity of 
the compounds that pass the screening. Toxicity 
prediction results using LD50 parameters, AMES 
mutagenic test, Hepatotoxicity, skin sensitization, 
and toxicity class shown in Table 3.
 Based on Table 4, the compounds are 
classified as toxicity class 5 (2000<LD50≤ 5000), 
which, according to GHS classification, are classified 
as drugs with low toxicity. In the classification of 
toxic levels in the GHS of classification and labeling 
of chemicals, it is mentioned that above doses of 
2000 mg/kgBW are included in the category of low 
toxicity and there are no safety symbols or warning 
signs in labeling that need to be included (Makiyah 
and Tresnayanti, 2017). According to Hodge and 
Sterner (1949) states that toxicity class 4 in GHS 
means that the compound has relatively low toxicity. 
Compounds classified as Class 3, where the risk of 
toxicity is higher than Class 4 and 5.
DISCUSSION
 This study aimed to predict the inhibitor 
of estrogen alpha and toxicity through in silico 
test of compounds in 96% ethanol extract of C. 
Figure 2. The two-dimensional interactions are shown between the test compounds against the ER-α chain 
C with native ligands and comperative drug.
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Figure 3. Two dimensions form of hydrogen and steric bonds between (A) native ligand (B) Tamoxifen 
(C) 2-Methyl-1,4-piperazinediyl) bis [(3,4,5-trimethoxyphenyl)-methanone] (D) Azoxyatrobin (E) 
Kaempferol (F) Genistein (G) 1-Acetyl-3-piperidinecarbohydrazide (H) (2R) -2-Amino-3-Trisulfanylpro-
panal (I) Isoleucine-Alanine dipeptide (J) Indoline (K) N- [(5-Chloro -1,2,3-thiadiazol-4-yl) methyl] -1- 
(2-isopropyl-4-methyl-1,3-thiazol-5-yl) -N-methylethanamine and (L) Isrhamnetin with ER-α (5W9C); 
blue lines as hydrogen bonds and red lines as steric bonds.
cinerariifolium leaves. The preliminary test of 
docking molecular in silico in this study was to 
screen compounds (Adnyani, et al., 2019). Based 
on Figure 1 shows that of the 35 compounds, ten 
compounds passed screening with parameters not 
penetrating the blood-brain barrier, P-GP non-
substrate, and based on the criteria of the Five 
Lipinski Rules. To avoid the toxicity and MDR in 
the body, in this research chose a compound that 
does not penetrating the blood-brain barrier and 
P-GP non-substrate.
 Another critical parameter in drug 
development is the physicochemical prediction 
of a compound, where the prediction based on 
the Five Lipinski Rules so that the drug has 
good permeability and good oral bioavailability 
(Hardjono, 2013). According to these rules, drug 
compounds must have a molecular weight of 
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Compounds 
Amino Acid Rerank Score 
Hydrogen Interaction S teric Interaction Electrostatic Interaction 
Indoline  -  Leu 387(C) - -46.9828 
Isoleucine-Alanine dipeptide  Glu 353(C) Ala 350(C), Leu 349(C), Glu 
353(C), Leu 346(C) 
Glu 353(C) -72.0238 
1-Acetyl-3-piperidine 
carbohydrazide 
- Val 533(C), Asp 351(C), Trp 
383(C), Leu 346(C) 
- -59.6584 
Kaempferol  G lu 353(C), Arg 394(C), 
Thr 347(C) 
Leu 391(C), Leu 384(C), Thr 
347(C), Ala 350(C), Arg 394(C), 
Glu 353(C), Leu 387(C) 
- -77.3413 
Isorhamnetin  Thr 347(C), Glu 353(C), 
Arg 394(C) 
Thr 347(C), Leu 384(C), Leu 
391(C), Ala 350(C), Leu 387(C), 
Glu 353(C), Arg 394(C) 
- -88.6277 
Genistein Glu 353(C), Arg 394(C), 
Gly 521(C), His 524(C) 
Leu 387(C), Arg 394(C), Glu 
353(C), Ala 350(C), Leu 346(C), 












Thr 347(C)  Asp 351(C), Leu 354(C), Val 
533(C), Trp 383(C), Ala 350(C), 
Thr 347(C), Leu 525(C), Leu 
346(C), Asn 532(C), Leu 387(C) 
- -107.4830 
Azoxystrobin  A rg 394(C) Ile 424(C), Phe 404(C), Leu 346(C), 





Leu 346(C), Arg 394(C), 
Glu 353(C) 
Leu 346(C), Glu 353(C), Arg 
394(C) 
- -50.0824 
Tamoxifen Asp 351 (C)  Asp 351(C) Asp 351(C) -94.7420 
4-Hydroxytamoxifen 
(Ligand Native) 
Glu 353(C), Arg 394(C) Asp 351(C), Val 533(C), Glu 
353(C), Arg 394(C) 
Asp 351(C) -112.3033 
Table 2. Interactions of Ligands with Amino Acids and Rerank Scores
less than 500 g/mol, a log P value of less than 5, 
Hydrogen Bond Donors (HBD) value of not more 
than 5, and Hydrogen Bond Acceptors (HBA) value 
of not more than 10. Research has further added 
two more criteria to make the oral bioavailability of 
a drug better. These criteria included: Topological 
Polar Surface Area (TPSA) with a value of ≤140 Å 
and rotating hydrogen bond (Torsion) with a value 
of ≤10 (Chagas, et al., 2018).
 In ordered to validate the scoring function, 
before redocking  molecules  for selecting 
prospective hits, we preparation into 5W9C protein 
structure in MVD. There are 4 chain of ER-α 
protein in 5W9C were each charged with its ligand. 
Subsequently, we compared the conformation 
and position with the bound ligand conformation 
measured regarding the rootmean square deviation 
(RMSD). 
 Based on the results in table 2, compounds 
Azoxystrobin and (2-Methyl-1,4-piperazinediyl) 
bis [(3,4,5-trimethoxy-phenyl) -methanone] show a 
smaller Rerank Score compared to Tamoxifen as a 
comparison drug, thus making the level of affinity 
for ER-α higher because of the lower energy 
required to bind to the receptors. This compound 
can be a candidate for ER-α positive breast cancer 
therapy. The smaller Rerank Score or bond energy 
indicates more stable bonds and results in increased 
activity. Bond energy stated the amount of energy 
needed to carry out interactions between ligands and 
receptors (Thomsen, et al., 2006; Kusumaningrum, 
et al., 2014).
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A*  B* C** D** E** 
Indoline 1250  4  No No Yes 
Isoleucine-Alanine dipeptide 3750  5  No No No 
1-Acetyl-3-piperidine carbohydrazide 650 4 Yes Yes No 
Kaempferol 3919  5  No No No 
Isorhamnetin 5000  5  No No No 




200 3 No  Yes No 
(2-Methyl-1,4-piperazinediyl)bis[(3,4,5-
trimethoxyphenyl)-methanone] 
1000  4  No No No 
Azoxystrobin 500 4 No  Yes No 
(2R)-2-Amino-3-Trisulfanylpropanal 156 3 No  No Yes 
Tamoxifen  1190  4  Yes  No No 
Table 3. Prediction of toxicity using Protox II online and pkCSM online tool
Note: LD50 (mg/kg) (A), Toxicity Class (B), AMES Mutagenic Test (C), Hepatoxicity (D), and Skin Sensitivity (E). 
         *Using Protox II Online Tool, **Using pkCSM Online Tool.
 The similarity of the amino acid residue Arg 
394 involved in the ER-α receptor binding process 
will cause compounds to inhibit receptor activity by 
competitive inhibitors (Figure 3). It was reported in 
a previous study that molecular interactions in Arg 
394 were assumed to be the bonds responsible for 
the computational chemical antagonistic activity 
which has potential pharmacological activities as 
inhibitors of ER-α breast cancer (Zein, et al., 2016). 
The role of Glutamic Acid (Glu) in hydrogen bonds 
has been described as having a role in inhibiting 
tumor development by suppressing the process 
of angiogenesis (Baek, et al., 2017). The amino 
acid Asp-351 in the ER-α receptor ligand binding 
domain plays an important role in regulating 
activities such as alpha estrogen inhibition from the 
SERM complex (Jordan, et al., 2015). 
 The interaction between ligand with 
amino acid Arg 394, Glu 353, and Asp 351 makes 
the ligand and ER-α interaction have lower bond 
energy or Rerank Score. So that the native ligand 
(4-hydroxytamoxifen) has the lowest Rerank Score 
than the other ligands. Shiau (1998) states that 
the interaction of 4-hydroxytamoxifen with ER-α 
causes changes in the 12th helical conformation 
which is a coactivator region, this conformational 
change causes the coactivator binding site to close 
so that the next signal transduction process does not 
occurand the cell proliferation process is inhibited.
CONCLUSION
 The compound in 96% ethanol extract 
of C. cinerariifolium leaves predicted in silico to 
inhibiting ER-α (PDB: 5W9C) as indicated by the 
interaction of active amino acids (Arg 394, Asp 351, 
Glu 353, and Val 533). There are two compounds 
have lower rerank score than the comparative drug 
(Tamoxifen). Test compounds also predicted to 
have relatively low toxicity.
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